With the power of artificial intelligence (AI) expanding exponentially, applications to the pharmaceutical industry are increasing in scale and frequency, overcoming major challenges in drug development. Computational methods offer strong advantages compared to traditional methods in curating functional antibodies against desired targets.
This webinar will detail how scientists at Antiverse used an AI-based approach to generate diverse and functional antibodies against hard-to-drug targets, including G-protein coupled receptors, with increased diversity, specificity, and affinity.
In this webinar you will:
-Learn how AI is revolutionizing the therapeutics pipeline.
-Hear Murat Tunaboylu explain how AI enabled the development of functional antibodies against desired targets .
-Discover how this successful approach reduced the drug discovery timeline to six months.
-Find out why Antiverse partnered with Twist to develop their high-quality antibody libraries.
